Clinical Trials on Primary Progressive Aphasia in Switzerland

Total 1015 results

University Hospital, Grenoble

Completed

Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease (META-DEM)

Healthy | Alzheimer Disease | Semantic Dementia

France, Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Recruiting

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis (INsIDER)

Multiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)

Switzerland
Klinik Valens
Technische Universität Dortmund, Germany

Recruiting

The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS (CYPRO)

Exercise | Cardiorespiratory Fitness | Primary Progressive Multiple Sclerosis

Switzerland
Alector Inc.

Active, not recruiting

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

Frontotemporal Dementia

Spain, United States, Portugal, United Kingdom, France, Germany, Netherlands, Belgium, Australia, Italy, Turkey, Switzerland, Argentina, Canada, Greece, Sweden
Casa Sollievo della Sofferenza IRCCS
Neurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...

Completed

Safety Study of Human Neural Stem Cells Injections for Secondary Progressive Multiple Sclerosis Patients (NSC-SPMS)

Secondary-progressive Multiple Sclerosis

Italy, Switzerland
University Hospital, Geneva

Completed

Effect of Dopaminergic Medication on Recovery of Aphasia

Aphasia

Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
University Hospital Inselspital, Berne
Haag-Streit AG

Completed

Evaluation Study for a Non-Contact Biometer

Cataract | Myopia | Hyperopia | Aphakia | Pseudophakia

Switzerland
Jean-Marie Annoni
University Hospital, Geneva; Hôpital Cantonal de Fribourg

Completed

Effect of Stimulation of the Prefrontal Cortex on Language Production in Aphasic Patients

Aphasia

Switzerland
Novartis Pharmaceuticals

Terminated

Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study (SWISSMASIA)

Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity

Switzerland
University Hospital Inselspital, Berne

Completed

Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity (PASP)

Aortic Valve Stenosis | Valvular Heart Disease | Aortic Valve Sclerosis | Stenosis Progression

Switzerland
Adrian Guggisberg

Recruiting

Effects of Transcranial Direct Current Stimulation (tDCS) on Brain Organization and Naming in Aphasic Patients.

Stroke | Aphasia

Switzerland
Klinik Valens

Active, not recruiting

Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up

Oncologic Disorders

Switzerland
European Organisation for Research and Treatment...
Amgen

Withdrawn

Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma (RIGOLETTO)

First Progression of MGMT Promoter-methylated Glioblastoma

Spain, Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2017_13

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2016_37

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
Sonova AG

Completed

Quality Control of CE-Certified Phonak Hearing Aids - 2017_27

Hearing Loss, Bilateral Sensorineural, Progressive

Switzerland
KemPharm Denmark A/S

Completed

A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C

Spain, France, United Kingdom, Switzerland, Denmark, Poland, Italy, Germany
IntraBio Inc

Active, not recruiting

A Pivotal Study of N-Acetyl-L-Leucine on Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C

United States, Australia, United Kingdom, Germany, Slovakia, Netherlands, Czechia, Switzerland
University of Bern
University Hospital Inselspital, Berne; Swiss National Science Foundation

Terminated

Does an Integrative Neuro-psychotherapy Program Foster the Adjustment in Depressed Stroke Patients? A Randomized Controlled Study.

Adjustment Disorders | Non-progressive Brain Injury

Switzerland
University of Bern

Completed

A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.

Aphasia | Chronic Stroke | Post Stroke Seizure

Switzerland
Simone Hemm-Ode

Completed

Picture Naming in the Context of Image Type and Response Variety in People With and Without Aphasia

Aphasia

Switzerland
ZevraDenmark

Active, not recruiting

Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C

Niemann-Pick Disease, Type C

United States, Spain, United Kingdom, Denmark, France, Germany, Italy, Poland, Switzerland
Klinik Valens

Recruiting

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis (TIME)

Multiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor Symptoms

Switzerland
University of Neuchatel

Completed

Treatment of Grammatical Time Marking in Post-Stroke Aphasia

Stroke | Aphasia | Brain Injury, Vascular

Switzerland
Novartis Pharmaceuticals

Terminated

This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. (INFORMS)

Primary Progressive Multiple Sclerosis

United States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
University Hospital, Basel, Switzerland

Active, not recruiting

Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple Sclerosis (SMSC)

Multiple Sclerosis

Switzerland
Prof. Dr. Jörg Leuppi
Kantonsspital Baselland Bruderholz; Institut für Hausarztmedizin Basel

Recruiting

Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD (RECUT)

Pulmonary Disease, Chronic Obstructive | Disease Exacerbation | Adverse Effect of Glucocorticoids and Synthetic Analogues

Switzerland
University Hospital Inselspital, Berne

Completed

Occupational Therapy in Patients With Multiple Sclerosis

Multiple Sclerosis | Apraxia

Switzerland
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)

Multiple Sclerosis

United States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
Hoffmann-La Roche

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)

Multiple Sclerosis, Primary Progressive

United States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
Hoffmann-La Roche

Completed

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

Multiple Sclerosis, Primary Progressive

United States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
Amoneta Diagnostics SAS
Assistance Publique - Hôpitaux de Paris; University Hospital, Geneva; University... and other collaborators

Unknown

ADDIA Proof-of-Performance Clinical Study (ADDIA)

Frontotemporal Lobar Degeneration | Progressive Supranuclear Palsy (PSP) | Dementia With Lewy Bodies (DLB) | Corticobasal Degeneration (CBD) | Alzheimer Disease (AD) | Parkinson Disease Dementia (PDD)

Belgium, France, Italy, Switzerland, Turkey
University Hospital Inselspital, Berne

Completed

Nutritional Assessment in Mitochondrial Cytopathy (NAMITO)

Mitochondrial Diseases | Mitochondrial Myopathies | Mitochondrial Cytopathies

Switzerland
Hoffmann-La Roche

Completed

Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.

Healthy Volunteer, Muscular Atrophy, Spinal

Switzerland
Johnson & Johnson Pharmaceutical Research & Development...
Janssen-Cilag International NV

Completed

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure (PRIMS)

Chronic Kidney Failure | Pure Red-Cell Aplasia

Poland, United Kingdom, Belgium, Germany, Spain, Portugal, Australia, Switzerland, Finland, Greece, Sweden, Netherlands, Norway, Ireland, Denmark
Zurich University of Applied Sciences

Completed

Identification of Endometriosis and Migraine Criteria in Women With the Comorbidity of Both Conditions in Comparison With Women Who Only Suffer From Endometriosis - A Pilot Study

Migraine | Endometriosis

Switzerland
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
University Hospital, Basel, Switzerland

Completed

Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

Primary Vascular Dysregulation

Switzerland
University Hospital Inselspital, Berne

Completed

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism (Targeting CaSR)

Primary Hyperparathyroidism

Switzerland
Centre Hospitalier Universitaire Vaudois
The Novartis Foundation

Recruiting

Primary Hyperparathyroidism and Gut Microbiota (HYPOGEUM)

Hyperparathyroidism, Primary

Switzerland
Insel Gruppe AG, University Hospital Bern
University of Bern

Recruiting

STREAM Trial - Biomarker (STREAM-Bio)

Statin Treatment for Primary Prevention

Switzerland
University of Bern
Swiss Federal Institute of Technology

Completed

Efficacy of Taiji Training as a Program for Stress Prevention

Stress | Primary Prevention | Adult | Tai ji

Switzerland
Kantonsspital Graubuenden
Klinik Hirslanden, Zurich

Completed

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

Neoplasms, Second Primary

Switzerland
University Hospital Inselspital, Berne

Terminated

Maturation of Follicles After Transplantation of Ovarian Tissue Into the Pelvic Wall and the Ovary (Ovartrans)

Infertility | Ovarian Failure, Premature

Switzerland
University of Zurich

Recruiting

Identification of New Inborn Errors of Immunity

Primary Immune Deficiency Disorder

Switzerland
University Hospital, Basel, Switzerland
Swiss Foundation for the Study of Muscular Diseases

Completed

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Giant Cell Arteritis | Large Vessel Giant Cell Arteriitis

Switzerland
University of Zurich

Recruiting

Pathophysiology of Inborn Immunodeficiencies

Primary Immune Deficiency Disorder

Switzerland
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)

Metastatic Non Small Cell Lung Cancer

Denmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
University Hospital, Basel, Switzerland

Completed

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study) (GOLD)

Primary Polydipsia

Switzerland

Clinical Trials on Primary Progressive Aphasia in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations